96P PAM50-based ROR indexes as a tool to individualize the use of neoadjuvant endocrine therapy in ER+/HER2- breast cancer
| Autor: | Lopez Velazco, J.I., Manzano, S., Elorriaga, K., Lahuerta Martinez, A., Álvarez, L.A., Etxabe Azkue, I., Huarte Martinez, M., Buch, E., Giménez Climent, J., Quiroga Garcia, V., Aragón, S., Paré, L., Prat, A., Alvarez Lopez, I., Muñoz Caffarel, M., Urruticoechea, A. |
|---|---|
| Zdroj: | In Annals of Oncology May 2022 33 Supplement 3:S168-S169 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|